Aurobindo Pharma subsidiary API facility gets one USFDA observation Ruchika Sharma10 May 2024 5:43 PM ISTHyderabad: Through a recent BSE filing, Aurobindo Pharma has informed that the United States Food and Drug Administration (US FDA) has concluded...
Cipla gets 1 inspectional observation from USFDA for Maha facility Ruchika Sharma9 May 2024 11:06 AM ISTMumbai: Pharma giant Cipla has informed through a recent BSE filing that the Company has received 1 inspectional observation in Form 483...
Alembic Pharma gets USFDA EIR for Panelav Oncology formulation facility Ruchika Sharma6 May 2024 11:31 AM ISTVadodara: Alembic Pharma has announced that the Company has received an Establishment Inspection Report (EIR) from the US Food and Drug...
Aurobindo Pharma arm gets 7 USFDA observations for Alwar facility Ruchika Sharma4 May 2024 12:30 PM ISTTelangana: Aurobindo Pharma has informed in a recent BSE filing that the United States Food and Drug Administration (US FDA) has concluded an...
Natco Pharma gets USFDA EIR on pharmacovigilance requirements Ruchika Sharma25 April 2024 5:44 PM ISTTelangana: Natco Pharma has informed in a BSE filing that the Company has received the Establishment Inspection Report (EIR) from the US Food and...
USFDA issues 10 observations for Zydus Lifesciences Jarod facility Ruchika Sharma24 April 2024 4:01 PM ISTAhmedabad: Zydus Lifesciences has informed in a BSE filing that the US Food and Drug Administration (USFDA) has concluded an inspection with...
USFDA issues EIR for Lupin Aurangabad facility Ruchika Sharma24 April 2024 11:46 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has received the Establishment Inspection Report (EIR) from the United States...
USFDA successfully concludes inspection at Piramal Pharma USA facility Ruchika Sharma18 April 2024 5:36 PM ISTMumbai: Piramal Pharma Limited has informed through a recent BSE filing that the US Food and Drug ADministration (US FDA) has issued an...
Marksans Pharma gets 5 inspectional observations from USFDA for Goa facility Ruchika Sharma18 April 2024 12:14 PM ISTMumbai: Marksans Pharma has received 5 inspectional observations in Form 483 from the US Food and Drug Administration (USFDA) at...
Granules India gets Zero 483's from USFDA for Unit V facility in AP Ruchika Sharma13 April 2024 12:08 PM ISTTelangana: Granules India has informed in a BSE filing that the Company's Unit V facility located at Anakapally, Visakhapatnam, Andhra ...
USFDA concludes inspection of Lupin Dabhasa facility with no observations Ruchika Sharma13 April 2024 11:48 AM ISTMumbai: Global pharma major Lupin Limited has announced that the United States Food and Drug Administration (U.S. FDA) has completed a GMP...
Sun Pharma receives OAI status from USFDA for Dadra facility Ruchika Sharma12 April 2024 11:42 AM ISTMumbai: Sun Pharma has informed in a BSE filing that the US Food and Drug Administration (USFDA) has determined the inspection classification...
